AL-S Pharma

Switzerland
Schlieren, Zurich, Switzerland, 8952

Company profile

AL-S Pharma company profile

AL-S Pharma AG develops AP-101, a human monoclonal antibody targeting misfolded SOD1 for the treatment of ALS.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2016-01-01, Year

Headquarters

Postal code
8952
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2016-12-08
Last equity funding
Seed
Investors
2
Articles
9

Categories and groups

Founders and investors

Investors

Neurimmune HoldingTVM Capital Life Science